Ardent Health (NYSE: ARDT) insider transactions
In the twelve months to 10 November 2026, executives and directors of Ardent Health reported 0 open-market sales and 2 open-market purchases of 21,260 shares ($186,400), by 2 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 25 September 2026 | Byers David Raynor | SVP & Chief Accounting Officer | Shares withheld for tax | −524 | $10.54 | 129,921 | Form 4 |
| 25 September 2026 | Petrovich Stephen C. | EVP, GC and Secretary | Shares withheld for tax | −788 | $10.54 | 773,919 | Form 4 |
| 25 September 2026 | Lumsdaine Alfred | Chief Financial Officer | Shares withheld for tax | −3,389 | $10.54 | 325,794 | Form 4 |
| 1 July 2026 | Caspers Dave | CEO and President | Grant or award | +103,653 | — | 174,930 | Form 4 |
| 5 June 2026 | Lumsdaine Alfred | Chief Financial Officer | Open-market purchase | +10,000 | $8.81 | 329,183 | Form 4 |
| 5 June 2026 | DeMichiei Robert | Director | Open-market purchase | +11,260 | $8.73 | 35,564 | Form 4 |
| 1 April 2026 | Bonick Martin | President and CEO | Shares withheld for tax | −10,952 | $8.67 | 1,303,322 | Form 4 |
| 1 April 2026 | Bonick Martin | President and CEO | Grant or award | +134,615 | — | 1,437,937 | Form 4 |
| 1 April 2026 | Lumsdaine Alfred | Chief Financial Officer | Shares withheld for tax | −4,381 | $8.67 | 265,337 | Form 4 |
| 1 April 2026 | Lumsdaine Alfred | Chief Financial Officer | Grant or award | +53,846 | — | 319,183 | Form 4 |
| 1 April 2026 | Byers David Raynor | SVP & Chief Accounting Officer | Shares withheld for tax | −924 | $8.67 | 118,907 | Form 4 |
| 1 April 2026 | Byers David Raynor | SVP & Chief Accounting Officer | Grant or award | +11,538 | — | 130,445 | Form 4 |
| 1 April 2026 | Petrovich Stephen C. | EVP, GC and Secretary | Shares withheld for tax | −1,808 | $8.67 | 749,803 | Form 4 |
| 1 April 2026 | Petrovich Stephen C. | EVP, GC and Secretary | Grant or award | +24,904 | — | 774,707 | Form 4 |
| 1 April 2026 | Caspers Dave | Chief Operating Officer | Shares withheld for tax | −2,684 | $8.67 | 35,604 | Form 4 |
| 1 April 2026 | Caspers Dave | Chief Operating Officer | Grant or award | +35,673 | — | 71,277 | Form 4 |
| 1 April 2026 | Bynoe Peter C B | Director | Grant or award | +14,231 | — | 115,367 | Form 4 |
| 1 April 2026 | Campion Suzanne | Director | Grant or award | +14,231 | — | 58,215 | Form 4 |
| 1 April 2026 | Goodyear William M | Director | Grant or award | +14,231 | — | 115,367 | Form 4 |
| 1 April 2026 | DeMichiei Robert | Director | Grant or award | +14,231 | — | 24,304 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Ardent Health page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.